Excellence in Biomaterials Science Award
The Excellence in Biomaterials Science Award by the Surfaces in Biomaterials Foundation (formerly known as the Excellence in Surface Science Award) recognizes an individual who has made significant contributions to the biomaterials science field. It is the highest award given by the Foundation. The first award was presented in 1991 to Buddy Ratner, University of Washington. The award is presented at the BioInterface Symposium.
The winner is notified before BioInterface and is invited to speak about the advancements made at the symposium.
Past Excellence in Surface Science Award Recipients
Rena Bizios, Ph. D., a chemical/biomedical engineer by training, is Lutcher Brown Chair Professor in the Department of Biomedical Engineering at the University of Texas at San Antonio. She pursued a career in academia. Her education-related contributions and research accomplishments have been recognized by several awards at the university, regional, and national levels. She is Fellow of six scientific/engineering national/international societies, The Academy of Medicine, Engineering and Science of Texas, and the National Academy of Medicine.
2018 Winner: Anna Belu
Anna Belu is a Senior Principal Scientist, Technical Fellow and Bakken Fellow at Medtronic plc in Corporate Science and Technology. Anna has over 25 years of experience in surface science, materials, and characterization, with a keen focus on medical devices and the biointerface for the past 20 years. At Medtronic, Anna leads the Microscopy and Surface Analysis team, is Chair of the Analytical Lab Council, and is Liaison to Coronary Structural Heart R&D. Anna received her B.S. in Chemistry from Denison University in Ohio, her Ph.D. in Analytical Chemistry from the University of North Carolina, and spent two years as a postdoctoral fellow at the University of Washington in the Department of Bioengineering. Her first industrial position was with Physical Electronics as a Staff Scientist for four years.
Anna’s enthusiasm for knowledge sharing and collaboration is evident through organizing symposia and conferences, and giving many invited talks and tutorials in the fields of surface analysis and biomaterials. Anna has over 40 publications. She has held leadership positions with several technical organizations, including Medtronic’s Technical Forum, the Society for Biomaterials, the Surfaces in Biomaterials Foundation, and the American Vacuum Society (AVS). Anna is a Fellow of the AVS and is currently serving as Trustee. She is a member of the Scientific Committee for the International Conference on Secondary Ion Mass Spectrometry (SIMS) and is Chair of the conference in 2021. Anna is an Associate Editor of the journals Biointerphases and Surface Science Spectra, and previously served as Editor of Biointerphases for four years.
2017 Winner: Victoria E. Carr-Brendel
Victoria E. Carr-Brendel, Ph.D. has over 25 years of medical device experience, including the development and commercialization of numerous advanced medical devices across disease states. She began her career with Baxter Healthcare in research and development of an artificial pancreas. She held increasingly higher roles within R&D. She has worked for startup companies within R&D in women’s healthcare (Adiana) and in glucose sensor technology (Dexcom). She worked for three divisions within Boston Scientific (Neurovascular, Electrophysiology, and Peripheral Interventions). Served as general manager of Boston Scientific’s Bayer Interventional business, executing on successful commercial growth and integration strategy. She is currently the Chief Executive Officer at JenaValve Technology, Inc. with operating locations in Munich, Germany, Leeds, England and Irvine, California. JenaValve develops, manufactures and markets transcatheter aortic valve repair (TAVR) systems to treat patients suffering from aortic valve disease. The Company’s Transapical TAVR system, consisting of the JenaValve valve system plus Cathlete PLUS delivery system, has CE Mark approval for aortic valve stenosis and for the unique indication to treat patients suffering from aortic valve insufficiency
2016 Winner: Antonios G. Mikos
Antonios G. Mikos is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. His research focuses on the synthesis, processing, and evaluation of new biomaterials for use as scaffolds for tissue engineering, as carriers for controlled drug delivery, and as non-viral vectors for gene therapy. His work has led to the development of novel orthopaedic, dental, cardiovascular, neurologic, and ophthalmologic biomaterials. Mikos is a Member of the National Academy of Engineering, the National Academy of Medicine, and the Academy of Medicine, Engineering and Science of Texas. He is a Fellow of the American Association for the Advancement of Science, the American Institute of Chemical Engineers, the American Institute for Medical and Biological Engineering, the Biomedical Engineering Society, the Controlled Release Society, the International Union of Societies for Biomaterials Science and Engineering, the Tissue Engineering and Regenerative Medicine International Society, and the National Academy of Inventors. He has been recognized by various awards including the Lifetime Achievement Award of the Tissue Engineering and Regenerative Medicine International Society-Americas, the Founders Award of the Society For Biomaterials, and the Robert A. Pritzker Distinguished Lecturer Award of the Biomedical Engineering Society.
2015 Winner: Gail Naughton
Dr. Gail Naughton founded Histogen, Inc. in 2007, and currently serves as CEO and Chairman of the Board for the Company. She has spent more than 30 years extensively researching the tissue engineering process, holds more than 100 U.S. and foreign patents, and has been extensively published in the field.
During her tenure at Advanced Tissue Sciences, where she was the company's co-founder and co-inventor of its core technology, Dr. Naughton oversaw the design and development of the world's first up-scaled manufacturing facility for tissue engineered products, established corporate development and marketing partnerships with companies including Smith & Nephew, Ltd., Medtronic and Inamed Corporation, was pivotal in raising over $350M from the public market and corporate partnerships, and brought four human cell-based products from concept through FDA approval and market launch.
In addition to this work, Dr. Naughton served as Dean of the College of Business Administration at San Diego State University from 2002 until 2011, where she helped to make SDSU the first campus in the nation to found a Ph.D./MBA in life sciences. In 2000, Dr. Naughton received the National Inventor of the Year award by the Intellectual Property Owners Association in honor of her pioneering work in the field of tissue engineering. She sits on the Board of directors of the CR Bard (NYSE: BCR) and the La Jolla Institute for Allergy and Immunology, as well as in the Advisory Board of Georgia Tech, the Ackerman Foundation, Perminova and the Centre for Commercialization of Regenerative Medicine.
2014 Winner: Thomas J. Fogarty
Dr. Thomas J. Fogarty is an internationally recognized cardiovascular surgeon, inventor, entrepreneur, and vintner. He has been involved with a wide spectrum of innovations in business and technology. Dr. Fogarty has served as founder/co-founder, and Chairman/Board Member of over 33 various business and research companies, based on medical devices designed and developed by Fogarty Engineering, Inc. During the past 40 years, he has acquired 135 surgical patents, including the “industry standard” Fogarty balloon catheter and the widely used Aneurx Stent Graft that replaces open surgery aortic aneurysm. Dr. Fogarty has received countless awards and honors; most significantly, he is the recipient of the Jacobson Innovation Award of the American College of Surgeons and the 2000 Lemelson-MIT prize for Invention and Innovation, and was inducted into the Inventors Hall of Fame and the National Academy of Engineering.
This award honors an outstanding researcher for significant contributions to surface science at the biointerface or an entrepreneur for practical application of surface science in the development of medical devices. The winner will present his or her work at the symposium Awards session.
2013 Winner: David Grainger
David W. Grainger is a University Distinguished Professor, the inaugural George S. and Dolores Doré Eccles Presidential Endowed Chair in Pharmaceutics and Pharmaceutical Chemistry, and Department Chair in the Department of Pharmaceutics and Pharmaceutical Chemistry. He is also a full Professor of Bioengineering at the University of Utah. Grainger received his Ph.D. in Pharmaceutical Chemistry from the University of Utah in 1987 studying blood-compatible polymers. He then received an Alexander von Humboldt Fellowship to perform postdoctoral research under Prof. Helmut Ringsdorf, University of Mainz, Germany. This training initiated over 25 years of experience with various aspects of developing “materials in medicine”. Grainger’s research expertise is focused on improving implanted medical device performance, drug delivery of new therapeutic proteins, nucleic acids and live vaccines, nanomaterials interactions with human tissues, low-infection biomaterials, and innovating diagnostic devices based on DNA and protein biomarker capture. Additionally, he is an expert in applications of surface analytical methods to biomedical interfaces, including analytical methods development for difficult organic surface patterns and nanomaterials, and also internationally recognized as an expert in perfluorinated thin films and biomaterials.
2012 Winner: Marcus Textor
Marcus Textor is a professor emeritus of ETH Zurich. He studied chemistry at the University of Zurich. Receiving a fellowship of the Royal Society, he spent two years as a postdoctoral fellow at the School of Molecular Sciences, University of Sussex, Brighton, UK. Research covered the preparation and characterization of single crystal surfaces, and the monitoring of catalytic model reactions at these surfaces in vacuo. In 1978 he took up an industrial position at Alusuisse R&D Laboratories, Switzerland, finally with world-wide R&D responsibilities for materials and surface aspects in the application of aluminium and composites for the industrial, automotive and packaging sectors. In 1994 he joined ETH Zurich, Department of Materials and established a research group and teaching program in the area of surfaces and interfaces of light metals and biointerfaces. His main interests in the last decade cover both fundamental, quantitative aspects in the behaviour of materials in contact with biological milieus and the design of surfaces that elicit biospecific responses on the level of proteins, cells/bacteria and tissue. His research activities aimed at developments for the field of biosensors, novel cell culture platforms, biomaterials/ medical devices, functional nanoparticles and smart carriers for drug delivery and medical imaging. He is a member of several international societies and received in 2006 an Award of The AVS Biomaterials Interface Division for substantial contributions to the field of Surfaces in Biotechnology. He has supervised 42 Ph.D. and 91 diploma/master theses and (co)-chaired 20 international conferences in the area of biomaterials, biotechnology and life sciences.
(No award was presented in 1992, 1993, 1994, 1995, 1997 or 1998)